Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Wiseone
    Junior Member
    • Apr 2010
    • 7

    #1

    Question on mapping reads

    Hey all,
    I am currently working with SE reads (75bp) from 4 independent samples. Sequencing generated approximately 25 million reads per sample (100 million total). My goal is to perform RNA seq to look at gene expression. I am using CLC workbench.
    Before I performed the de novo assembly I filtered reads less than 15 bp long and with greater than 2 uncalled bases (N). After performing the de novo assembly on the 100 million reads I get approximately 193000 contigs, with a min size of 100bp.
    I have begun performing the RNA seq and the first thing I noticed was that only approximately 30% of the reads from the individual samples are mapping back to the contigs. Am I right in saying that this number is very low? The unmapped reads are a mix of long and short reads, they appear to be high quality, and when I randomly blast them with blastn I get strong matches to sequences from related species. I tried relaxing the mapping parameters some but it only increased the number of reads mapping by 5%.
    I am very much beginner when it comes to this technology and what I have learned so far comes from trial and error on my part, as well as a question or two that I have posted on this forum. It seems to me that if you are mapping reads to contigs generated from those reads then the mapping efficiency should be much higher than 30-35%. I will continue to play with the mapping and the de novo assembly to try and improve the mapping but I was hoping someone on here could comment and maybe provide some insight into this.
    Thanks!

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...